While some users struggle with insomnia, a larger number report that their sleep has dramatically improved since starting tirzepatide
Key Highlights: 48 PSGs for products with no approved ANDAs (25 complex products) 39 PSGs for complex products (6 new, 33 revised) Therapies for COPD, opioid overdose, type 2 diabetes, major depressive disorder, and more Notable PSGs: Ensifentrine inhalation suspension (COPD, RLD: OHTUVAYRE) Naloxone hydrochloride nasal spray (Opioid overdose, RLD: REZENOPY) Semaglutide oral tablet (Type 2 diabetes, RLD: RYBELSUS) Trazodone hydrochloride ER oral tablet (MDD, RLD: OLEPTRO) Link : By publishing PSGs, FDA continues to promote innovation in generic development while advancing public health and patient access to cost-effective medicines
The primary patents extend through approximately 2032, though the exact date depends on potential patent extensions and legal challenges
Valid for 12 months since the production date
Other things to consider Now, if youre reading this and thinking But Jamie, I already AM doing all of these things and Im STILL not losing weight!!! I hear you and I see you
